New drug combo aims to beat back relapsed leukemia
NCT ID NCT06788756
First seen Jun 25, 2026 · Last updated Aug 06, 2026 · Updated 3 times
Summary
This study tests a new chemotherapy drug, L-Annamycin, combined with standard cytarabine in adults with acute myeloid leukemia (AML) that has come back or not responded to first treatment. About 312 participants will receive either the new drug combo or a placebo plus cytarabine. The goal is to see if L-Annamycin helps more people achieve complete remission after one cycle of treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- L-Annamycin (a chemotherapy drug) combined with cytarabine
- What this could lead to
- If successful, this could offer a new second-line treatment option for adults with AML that has not responded to or returned after initial therapy.
- What could go wrong
- This is an early-to-mid-stage trial, so the drug may not prove more effective than placebo. Chemotherapy side effects like infection and organ damage are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKAEMIA (AML) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AOU Careggi
RECRUITINGFlorence, 50134, Italy
-
ARENSIA Exploratory Medicine, LLC
RECRUITINGKyiv, 01135, Ukraine
-
ARENSIA research clinic at the Oncology Institute "Prof. Dr. Ion Chiricuţă"
RECRUITINGCluj-Napoca, 400015, Romania
-
AUSL della Romagna - Santa Maria delle Croci - Ravenna
RECRUITINGRavenna, 48121, Italy
-
Atlantic Health
RECRUITINGMorristown, New Jersey, 07960, United States
-
Augusta University - Georgia Cancer Center
RECRUITINGAugusta, Georgia, 30912, United States
-
Bioresearch Partners
RECRUITINGMiami, Florida, 33155, United States
-
Caucasus Medical Center
RECRUITINGTbilisi, 0186, Georgia
-
Fakultní nemocnice Hradec Králové
RECRUITINGHradec Králové, 500 05, Czechia
-
Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart
RECRUITINGRoma, 00168, Italy
-
GEORGIA: LLC ARENSIA Exploratory Medicine
RECRUITINGTbilisi, 0112, Georgia
-
Hospital MD Anderson Cancer Center Madrid
RECRUITINGMadrid, 28033, Spain
-
Hospital Universitario Central de Asturias (HUCA)
RECRUITINGOviedo, Principality of Asturias, 33011, Spain
-
Hospital Universitario La Fe de Valencia
RECRUITINGValencia, 46026, Spain
-
Hospital Universitario Ramón y Cajal
RECRUITINGMadrid, 28034, Spain
-
Institut Català d'Oncología (ICO) - Hospital Germans Trias i Pujol
RECRUITINGBarcelona, Badalona, 08916, Spain
-
Instytut Hematologii i Transfuzjologii, Klinika Hematologii
RECRUITINGWarsaw, 02-776, Poland
-
LSMU Kauno klinikos
RECRUITINGKaunas, LT-50161, Lithuania
-
Oddział Hematologii i Transplantacji Szpiku, Uniwersytecki Szpital Kliniczny w Poznaniu
RECRUITINGPoznan, 60-569, Poland
-
RCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia
RECRUITINGBologna, 40138, Italy
-
Szpital Kliniczny MSWiA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie Oddział Kliniczny Hematologii i Chorób Wewnętrznych z Ośrodkiem Transplantacji Szpiku
RECRUITINGOlsztyn, 10-228, Poland
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
-
University of Alabama Birmingham
RECRUITINGBirmingham, Alabama, 35249, United States
-
University of Nebraska Medical Center
RECRUITINGOmaha, Nebraska, 68198, United States
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19117, United States
-
University of Rhode Island
RECRUITINGProvidence, Rhode Island, 02903, United States
-
Uniwersytecki Szpital Kliniczny Klinika Hematologii i Transplantologii (Szczecin)
RECRUITINGSzczecin, 71-252, Poland
-
Wojewódzki Szpital Zespolony im. L. Rydygiera w Toruniu, Oddział Hematologii
RECRUITINGTorun, 87-100, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for AML patients: experimental drug IPN60340 enters key trial
- New blood test could personalize AML treatment
- Why do some Low-Risk leukemia patients relapse? scientists look to bone marrow cells for answers
- New drug cocktail aims to wipe out lingering leukemia
- Small study checks kidney and race impact on transplant drug
- New combo aims to keep leukemia at bay after remission